P&G Health Ltd (formerly Procter & Gamble td) (erstwhile Merck Limited) is engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals. Presenting below are its Q1 FY26 earnings results.
Q1 FY26 Earnings Results
-
Revenue from Operations: ₹338.74 crores, up 19.3% YoY (Q1 FY25: ₹283.88 crores) and up 9% QoQ (Q4 FY25: ₹310.99 crores).
-
Total Income: ₹342.77 crores, up 19.8% YoY (Q1 FY25: ₹286.01 crores), up 9.1% QoQ (Q4 FY25: ₹314.10 crores).
-
Total Expenses: ₹253.84 crores, up 7.8% YoY (Q1 FY25: ₹235.44 crores), up 7.8% QoQ (Q4 FY25: ₹235.44 crores).
-
EBIT: ₹88.93 crores, up 289% YoY from ₹22.83 crores.
-
Profit Before Tax (PBT): ₹88.81 crores, up 289% YoY (Q1 FY25: ₹22.83 crores).
-
Profit After Tax (PAT): ₹66.18 crores, up 288% YoY (Q1 FY25: ₹16.78 crores), up 8% QoQ (Q4 FY25: ₹61.18 crores).
-
Net Profit Margin: 19.3% (Q1 FY25: 5.9%).
-
EPS: ₹39.87, up from ₹10.11 in Q1 FY25 and ₹36.86 in Q4 FY25.
-
EBIT Margin: 25.94% (Q1 FY25: 8.05%).
-
Cash Position: Strong, with broad-based performance in domestic and export business.
Management Commentary & Strategic Decisions
-
MD Milind Thatte cited momentum and strong start to FY26, driven by superior brand building, market initiatives, and improved supply chain capabilities.
-
Strategy focused on a portfolio of highly recommended health brands (Neurobion, Livogen, SevenSeas, Evion, Polybion, Nasivion), performance-driven brand choice, and constructive disruption.
-
Company highlighted disciplined cost management, operational efficiencies, and meaningful innovation to achieve balanced and sustainable growth.
-
Continued engagement with consumers and healthcare professionals through innovation backed by science and community initiatives remains a priority.
Q4 FY25 Earnings Results
-
Revenue from Operations: ₹310.99 crores.
-
Total Income: ₹314.10 crores.
-
Total Expenses: ₹230 crores.
-
PAT: ₹61.18 crores.
-
EPS: ₹36.86.
-
Net Profit Margin: 19.5%.
To view the company’s previous earnings and latest concall transcripts, click here to visit the Alphastreet India news channel.
Most Popular
Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
All you need to know about Antony Waste Handling Cell in one article
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
Demystifying the Leading Non-Ferrous Recycling Company of India
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,